ANGELA RUTLEDGE: Open Payments
NPI 1871994913 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 44 payments from 12 companies in 2025. Trend: 2023 $678 · 2024 $648 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $205 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $201 |
| ABBVIE INC. | 10 | $137 |
| Insulet Corporation | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Exact Sciences Corporation | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $15 |
Products named: CAPLYTA, Rybelsus, VRAYLAR, UBRELVY, Omnipod, Ozempic, Wegovy, Veozah.
Industry payments across KY — which companies pay providers there.
